Stay updated with breaking news from Medicine ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ Texas Children s Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit COVID-19 Vaccine, whose technology. ....
/PRNewswire/ Texas Children s Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit COVID-19 Vaccine, whose technology. ....
Texas Children's Hospital And Baylor College of Medicine COVID-19 Vaccine Technology Secures Emergency Use Authorization In India streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Deerfield Management and Baylor College of Medicine Announce Blue Square Discoveries to Advance Novel Therapeutic Treatments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Biological E to begin phase 3 trials for COVID-19 vaccine By Yunus Y Lasania| Published: 24th April 2021 5:24 pm IST Hyderabad: Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) today announced that it has successfully completed the phase I/II clinical trials of its COVID-19 subunit vaccine candidate in India. The company has also received approval to start phase III clinical trials from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC). The phase III clinical study to be conducted in 15 sites across India, and will evaluate the Immunogenicity and Safety of Biological E’s SARS-CoV-2 COVID-19 vaccine for protection against COVID-19 disease in about 1268 healthy subjects in the age range of 18 to 80 years. It is intended to be part of a larger global Phase III study, the company stated. ....